Toronto, Ontario–(Newsfile Corp. – October 26, 2023) – Safe Supply Streaming Co. Ltd. (CSE: SPLY) (“Safe Supply” or the “Company“), the first company investing in and incubating companies at the forefront of the third wave of drug policy reform, announced today that it has appointed Ronan Levy as President of the Company.

A pioneer in the cannabis and psychedelics industries, and a qualified lawyer in Ontario, Levy joins Safe Supply with over 15 years of capital markets experience. Prior to joining Safe Supply, Ronan served as Co-founder and Executive Chairman of Reunion Neuroscience Inc. (acquired by MPM BioPharma in 2023) and Chairman and CEO of Field Trip Health & Wellness Ltd. Before that, Ronan Co-founded Canadian Cannabis Clinics and CanvasRx, which were acquired by Aurora Cannabis Inc. (NASDAQ: ACB) in 2016, where he served as Senior Vice President, Business & Corporate Affairs following the acquisition.

“We are delighted to have Ronan join Safe Supply as President. His many years of experience building the cannabis and psychedelics industries gives him the knowledge, experience, and connections to help us execute our mission to help bring a responsible end to the drug war,” said Bill Panagiotakapoulos, Safe Supply’s CEO.

In addition to his work at Safe Supply, Levy is a Co-founder of The Non-Ordinary Therapy Company Ltd., a company focused on enhancing and extending periods of neuroplasticity, a Co-founder of Harbour Coca, the world’s leading coca leaf company, and a member of the board of directors of Trait Biosciences Inc., a cannabis biotech company based in Los Alamos, New Mexico and WRKOUT, a platform that is transforming the fitness industry by synergistically connecting trainers, coaches, clients, and brands. He is also the author of two books, The Ketamine Breakthrough (Hay House) and The Trip Journal (Libra Press), and is the host of The Non-Ordinary Podcast.

“Much of my professional career has been dedicated to helping bring a responsible end to the war on drugs. That motivation, along with my belief in the incredible therapeutic potential of plant-based medicines, is what inspired my work in the cannabis and psychedelics industries,” said Levy. “Joining Safe Supply, which is advancing that work in a much broader sense, is a natural fit for me. Moreover, the team of former CEOs that Bill has brought together to lead Safe Supply, who collectively have decades of experience, is one of the most impressive I’ve seen. It gives me great confidence in the positive impact Safe Supply’s work will have on this world and the significant investment opportunity that it is creating. “

Levy’s role at Safe Supply will, among other things, focus on helping to develop Safe Supply’s brand, establishing its investing strategy, and working closely with Safe Supply’s investee companies to help develop their business models and strategies.

About Safe Supply

With a mission to help bring a responsible end to the war on drugs, Safe Supply Streaming Co. Ltd. is investing in and incubating companies at the forefront of the third wave of drug policy reform. As jurisdictions around the world move to decriminalize, regulate and legalize drugs, Safe Supply is investing in the infrastructure necessary to support the transition. From developing the facilities to analyze, manufacture and distribute psychoactive compounds including the coca plant, to investing in the research and innovation to harness the potential, and minimize the harm, of these medicines, to constructing the clinical infrastructure to ensure safe and responsible access and treatment, Safe Supply is building a platform of tightly woven companies that will help save millions of lives and build a safer, healthier post-war on drugs worlds.

Learn more at www.safesupply.com and follow Safe Supply on LinkedIn, Twitter, and Instagram.

For Further Information:

Bill Panagiotakopoulos
Chief Executive Officer and Director
Safe Supply Streaming Co. Ltd.
www.safesupplystreaming.com
[email protected]

Media contacts:
McKenna Miller
KCSA Strategic Communications
[email protected]

Forward-Looking Information and Statements

Certain statements in this news release related to Safe Supply are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These forward-looking statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe”, “will” or “continue”, or the negative thereof or similar variations. There are numerous risks and uncertainties that could cause actual results and Safe Supply’s plans and objectives to differ materially from those expressed in the forward-looking information, including but not limited to adverse market conditions and risks inherent in Safe Supply’s business. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this press release. Except as required by applicable law, Safe Supply does not intend to update these forward-looking statements. Trading in the securities of Safe Supply should be considered highly speculative.

The CSE has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.